Dexcom (DXCM) Market Capitalization (2010 - 2026)

Dexcom (DXCM) has reported Market Capitalization for 17 consecutive years, with $25.4 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization fell 25.75% year-over-year to $25.4 billion in Q2 2026; TTM through Jun 2026 was $25.4 billion, a 25.75% decrease from a year earlier, with the FY2025 full-year figure at $25.5 billion, down 15.95% from the prior year.
• Market Capitalization was $25.4 billion for Q2 2026 at Dexcom, up from $24.2 billion in the prior quarter.
• Over five years, Market Capitalization peaked at $54.9 billion in Q1 2024 and troughed at $24.2 billion in Q1 2026.
• A 5-year average of $36.2 billion and a median of $32.7 billion in 2022 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization jumped 69.57% in 2023 and plunged 51.26% in 2025, its largest moves.
• Over 5 years, Market Capitalization stood at $43.7 billion in 2022, then increased by 9.33% to $47.8 billion in 2023, then tumbled by 36.47% to $30.4 billion in 2024, then slipped by 15.95% to $25.5 billion in 2025, then slipped by 0.47% to $25.4 billion in 2026.
• The last three Market Capitalization figures came in at $25.4 billion (Q2 2026), $24.2 billion (Q1 2026), and $25.5 billion (Q4 2025), per Business Quant data.